Fibromyalgia

Duloxetine, milnacipran and pregabalin can yield significant pain relief over at least 12 weeks for approximately one out of 10 adults with fibromyalgia, according to an analysis of Cochrane reviews published in Rheumatology.

WASHINGTON — Approximately 20% of patients meeting the 2016 fibromyalgia criteria report post-exertional malaise, which itself may be key to understanding both long COVID and fatigue in patients with rheumatic diseases, according to data.

Long-term use of skeletal muscle relaxants may be beneficial only for the treatment of a narrow subset of chronic pain conditions, according to the findings of a systematic review published in JAMA Network Open.

Odds of developing chronic pain conditions were doubled for women who experienced domestic violence in adulthood vs. those without a history of violence, according to a systematic review and meta-analysis published in BMC Women’s Health.

The FDA has granted fast track designation to a sublingual tablet form of the muscle relaxant cyclobenzaprine hydrochloride for the management of fibromyalgia, according to a press release from the manufacturer.

Women with chronic pelvic pain have more ED visits, imaging tests and hysterectomies and higher rates of overlapping chronic pain conditions vs. women without chronic pelvic pain, according to findings published in Obstetrics & Gynecology.

Rheumatoid arthritis and fibromyalgia are among the most common comorbidities identified in patients following a diagnosis of osteoarthritis, according to data presented at the EULAR 2024 Congress.

DESTIN, Fla. — The course of difficult-to-treat psoriatic arthritis can be significantly impacted by a host of factors beyond choice of therapy, according to data presented at the Congress of Clinical Rheumatology East annual meeting.

Ultrasound can differentiate spondyloarthritis-related enthesitis from other entheseal pathologies such as mechanical enthesitis, according to data published in Annals of the Rheumatic Diseases.